OTC Markets OTCPK - Delayed Quote USD
Novo Nordisk A/S (NONOF)
61.55
-2.00
(-3.15%)
At close: April 24 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
120,968,000
120,968,000
108,908,000
78,887,000
55,000,000
Investing Cash Flow
-128,895,000
-128,895,000
-43,892,000
-24,918,000
-31,605,000
Financing Cash Flow
8,735,000
8,735,000
-63,158,000
-51,797,000
-25,493,000
End Cash Position
15,655,000
15,655,000
14,392,000
12,653,000
10,719,000
Capital Expenditure
-51,309,000
-51,309,000
-38,896,000
-14,753,000
-7,385,000
Issuance of Debt
79,391,000
79,391,000
--
11,215,000
22,160,000
Repayment of Debt
-6,335,000
-6,335,000
-1,467,000
-13,623,000
-6,689,000
Repurchase of Capital Stock
-20,181,000
-20,181,000
-29,924,000
-24,086,000
-19,447,000
Free Cash Flow
69,659,000
69,659,000
70,012,000
64,134,000
47,615,000
12/31/2021 - 2/22/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RHHBF Roche Holding AG
355.38
0.00%
NVSEF Novartis AG
111.41
0.00%
RHHVF Roche Holding AG
318.68
+0.58%
AZNCF AstraZeneca PLC
137.24
0.00%
PFE.F Pfizer Inc.
20.05
+0.41%
GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
2,802.70
-3.89%
ROG.SW Roche Holding AG
262.40
+0.04%
PFE.DE Pfizer Inc.
20.06
+0.10%
RHHBY Roche Holding AG
39.75
+0.03%
AZN AstraZeneca PLC
69.55
+1.52%